Condition

Durvalumab clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Durvalumab clinical trials that are recruiting, at sites in 2 countries (most in Taiwan (2), China (1)). By phase: Phase 2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Durvalumab clinical trials

StudyPhaseWhereStatusRegistered
Photon radiotherapy plus tremelimumab and durvalumab for intermediate or advanced hepatocellular carcinoma Phase 2 Taoyuan City, Taiwan Recruiting May 31, 2025
Proton radiation with tremelimumab and durvalumab for BCLC stage B/C hepatocellular carcinoma Phase 2 Taoyuan City, Taiwan Recruiting May 31, 2025
Combining HAIC with Durvalumab and Lenvatinib for Advanced Intrahepatic Cholangiocarcinoma Phase 2 Chengdu, Sichuan Recruiting Mar 5, 2025

All recruiting trials (3)

Related topics

DurvalumabHCC - Hepatocellular CarcinomaTremelimumabIntrahepatic Cholangiocarcinoma (Icc)RadiotherapyLenvatinib

Quick answers

How many Durvalumab clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in Taiwan (2 trials), China (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.